MetaComp launches the world’s first AI agent governance framework for regulated financial services

4 days ago

Introduced at Money20/20 Asia, the StableX Know Your Agent Framework establishes how AI agents are identified, authorised, monitored and held…

TV Rheinland Opens Advanced Automotive Component Testing Laboratory in Manesar, Haryana

4 days ago

Empowering automotive industry capabilities through precision testing, international compliance, and innovative solutions for next-generation mobility.MANESAR, India, April 22, 2026 /PRNewswire/…

Changan Group Advances Global Strategy with “1+4+4+5” Framework, Targeting RMB 600 Billion in Revenue by 2030

4 days ago

CHONGQING, China, April 21, 2026 /PRNewswire/ -- The Group sets out Six Major Leaps and five doubling targets, with RMB 600…

HarperCollins is proud to announce the forthcoming publication of A Beginner’s Guide to the Indian Stock Market by Karthik Rangappa

4 days ago

Paperback | Non-Fiction | 228 pp | INR 499; Pre-Order now | Releasing 24th April 2026NEW DELHI, April 21, 2026 /PRNewswire/…

Total Investment of Approx. USD 8.5 Million in Malaria and NTD R&D Projects With Partners Including MMV, GSK, Tanabe Pharma, Eisai and DNDi

4 days ago

TOKYO, April 22, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY…

Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting

5 days ago

Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability scores, and eliminated the need for chronic immunotherapies…

RNK Health NAD+ Longevity Therapy Claims Evaluated: The Clinician-Guided NAD Injections & Medication Protocol

5 days ago

Des Moines, IA, April 21, 2026 (GLOBE NEWSWIRE) -- The information below contains affiliate links. If a purchase is made…

Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting

5 days ago

REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing…

AvePoint to Announce First Quarter 2026 Financial Results on May 7

5 days ago

JERSEY CITY, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT; SGX: AVP), the global leader in AI data protection,…

NewHydrogen Completes Critical Pre-Pilot Plant Technical Validation

5 days ago

The Company greenlights construction of a ThermoLoop engineering test unit to define commercial pilot plant specifications SANTA CLARITA, Calif., April…